Bronchoscopy diagnosis and treatment
Conditions
Interventions
Propofol Group:Sedative drug is propofol
Sponsors
Shanghai Pulmonary Hospital, Tongji University
Eligibility
Sex/Gender
All
Age
65 Years to No maximum
Inclusion criteria
Inclusion criteria: (1) Patients undergoing elective general anesthesia bronchoscopy and requiring laryngeal mask/tracheal tube placement; (2) Age = 65 years; (3) ASA class I-IV; (4) Voluntary participation and signed informed consent; (5) Voluntary and capable of completing telephone follow-up within three days after the bronchoscopy
Exclusion criteria
Exclusion criteria: (1) bronchoscopy outside the bronchoscopy room; (2) known allergy to rimazolam, propofol, remifentanil, rocuronium bromide, and sugammadex; (3) current non-invasive/invasive mechanical ventilation status; (4) current treatment with opioids or benzodiazepines of any kind; (5) history of drug or alcohol abuse; (6) patients with cognitive impairment; (7) For other reasons deemed by the investigator to be unsuitable for participation in the clinical trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sedation success rate;Abnormal respiratory rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Heart rate;Blood pressure;Effective time;Awakening time;Incidence of delayed awakening;Incidence of agitation during awakening;Incidence of drug injection pain; | — |
Countries
China
Contacts
Public ContactDuan Ruowang
Shanghai Pulmonary Hospital, Tongji University
Outcome results
None listed